Logo image of BLDE

BLADE AIR MOBILITY INC (BLDE) Stock Fundamental Analysis

NASDAQ:BLDE - Nasdaq - US0926671043 - Common Stock - Currency: USD

3.56  -0.26 (-6.81%)

After market: 3.5304 -0.03 (-0.83%)

Fundamental Rating

3

Overall BLDE gets a fundamental rating of 3 out of 10. We evaluated BLDE against 23 industry peers in the Passenger Airlines industry. BLDE has a great financial health rating, but its profitability evaluates not so good. BLDE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BLDE has reported negative net income.
BLDE had a negative operating cash flow in the past year.
BLDE had negative earnings in 4 of the past 5 years.
In the past 5 years BLDE always reported negative operating cash flow.
BLDE Yearly Net Income VS EBIT VS OCF VS FCFBLDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -18.19%, BLDE is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
BLDE has a Return On Equity (-22.04%) which is in line with its industry peers.
Industry RankSector Rank
ROA -18.19%
ROE -22.04%
ROIC N/A
ROA(3y)-13.03%
ROA(5y)-30.8%
ROE(3y)-15.88%
ROE(5y)-46.36%
ROIC(3y)N/A
ROIC(5y)N/A
BLDE Yearly ROA, ROE, ROICBLDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

With a Gross Margin value of 24.73%, BLDE is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for BLDE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLDE Yearly Profit, Operating, Gross MarginsBLDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

BLDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLDE has been increased compared to 1 year ago.
BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLDE Yearly Shares OutstandingBLDE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M
BLDE Yearly Total Debt VS Total AssetsBLDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

BLDE has an Altman-Z score of 3.51. This indicates that BLDE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.51, BLDE belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.51
ROIC/WACCN/A
WACC9.59%
BLDE Yearly LT Debt VS Equity VS FCFBLDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

BLDE has a Current Ratio of 6.32. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
BLDE has a Current ratio of 6.32. This is amongst the best in the industry. BLDE outperforms 95.65% of its industry peers.
A Quick Ratio of 6.32 indicates that BLDE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.32, BLDE belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.32
Quick Ratio 6.32
BLDE Yearly Current Assets VS Current LiabilitesBLDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

BLDE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.43%.
BLDE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.03%.
EPS 1Y (TTM)-31.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)12.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.81%

3.2 Future

Based on estimates for the next years, BLDE will show a very strong growth in Earnings Per Share. The EPS will grow by 24.52% on average per year.
Based on estimates for the next years, BLDE will show a very strong growth in Revenue. The Revenue will grow by 22.44% on average per year.
EPS Next Y56.38%
EPS Next 2Y30.31%
EPS Next 3Y21.92%
EPS Next 5Y24.52%
Revenue Next Year8.69%
Revenue Next 2Y7.2%
Revenue Next 3Y7.76%
Revenue Next 5Y22.44%

3.3 Evolution

BLDE Yearly Revenue VS EstimatesBLDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
BLDE Yearly EPS VS EstimatesBLDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLDE. In the last year negative earnings were reported.
Also next year BLDE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDE Price Earnings VS Forward Price EarningsBLDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDE Per share dataBLDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as BLDE's earnings are expected to grow with 21.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.31%
EPS Next 3Y21.92%

More info and screens

0

5. Dividend

5.1 Amount

BLDE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLADE AIR MOBILITY INC

NASDAQ:BLDE (2/21/2025, 8:03:43 PM)

After market: 3.5304 -0.03 (-0.83%)

3.56

-0.26 (-6.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-18 2025-03-18/amc
Inst Owners66.43%
Inst Owner Change5.31%
Ins Owners8.97%
Ins Owner Change-9.36%
Market Cap278.78M
Analysts84.44
Price Target8.33 (133.99%)
Short Float %3.6%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-53.51%
Min EPS beat(2)-145.1%
Max EPS beat(2)38.08%
EPS beat(4)2
Avg EPS beat(4)-75.51%
Min EPS beat(4)-246.02%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-26.36%
EPS beat(12)8
Avg EPS beat(12)-1.38%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.07%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)5.54%
Revenue beat(4)2
Avg Revenue beat(4)0.61%
Min Revenue beat(4)-3.83%
Max Revenue beat(4)5.54%
Revenue beat(8)6
Avg Revenue beat(8)4.05%
Revenue beat(12)10
Avg Revenue beat(12)9.81%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)53.13%
EPS NQ rev (1m)23.53%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)6.47%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-7.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 1.58
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS3.09
BVpS2.98
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.19%
ROE -22.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.73%
FCFM N/A
ROA(3y)-13.03%
ROA(5y)-30.8%
ROE(3y)-15.88%
ROE(5y)-46.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 448.76%
Cap/Sales 11.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.32
Quick Ratio 6.32
Altman-Z 3.51
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)30.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y56.38%
EPS Next 2Y30.31%
EPS Next 3Y21.92%
EPS Next 5Y24.52%
Revenue 1Y (TTM)12.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.81%
Revenue Next Year8.69%
Revenue Next 2Y7.2%
Revenue Next 3Y7.76%
Revenue Next 5Y22.44%
EBIT growth 1Y-17.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year101.61%
EBIT Next 3Y34.11%
EBIT Next 5Y27.14%
FCF growth 1Y-32.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.01%
OCF growth 3YN/A
OCF growth 5YN/A